Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

At-home full-body stimulation suit to manage spasticity and ataxia in MS

Official title: Home-Based Neuromodulation Suits for Reducing Spasticity and Ataxia in Multiple Sclerosis: A Multi-center RCT

Run by Universitair Ziekenhuis Brussel · NCT07202195 · Data updated 2026-11-12

This project will try whether wearing a full-body electrical stimulation suit for six weeks helps people with MS who have spasticity or ataxia reduce symptoms and improve daily functioning.

More Multiple Sclerosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorUniversitair Ziekenhuis Brussel
Academic / other
Locations2 sites (Steenokkerzeel and 1 other locations)
StatusRecruiting
StartedMarch 16, 2026
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedOctober 8, 2026
Trial IDNCT07202195 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a confirmed diagnosis of multiple sclerosis who have spasticity (MAS ≥ 1) or ataxia (SARA ≥ 4) and who can understand instructions and complete questionnaires are the intended participants.

Probably not a fit

People with implanted electronic devices, recent relapse or recent changes in disease-modifying treatment, recent Botulinum toxin A, acute musculoskeletal problems, or insufficient cognitive ability are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study compares two groups of people with MS: an intervention group who will wear a full-body electrostimulation suit and a control group who will receive usual care. Intervention participants wear the suit during a one-week admission at the MS center and then at home for five additional weeks, using it daily or every other day. Clinical tests are performed at the MS center after 1 week and after 6 weeks to measure spasticity, ataxia, and functional changes. Usual care continues for both groups throughout the study.

Why it matters

Potential benefit: If successful, the suit could reduce muscle stiffness and improve coordination and everyday mobility for people with MS.

How similar studies have gone: Small studies of targeted electrical neuromodulation have shown mixed benefits for MS symptoms, but full-body stimulation suits are a relatively novel approach with limited published evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligible participants must have ataxia or spasticity alongside impairments in upper or lower extremity physical function. MAS score ≥ 1 will be used as an inclusion criterion to determine the presence of spasticity. SARA score ≥ 4 will be used as an inclusion criterion to determine the presence of ataxia. Note: one of the two criteria (MAS score or SARA score) must be fulfilled for a pwMS to be eligible.
* The patient must have the cognitive abilities to understand instructions and to be able to complete the questionnaires adequately
* Diagnosis of multiple sclerosis.

Exclusion Criteria:

* Implanted devices (like pacemaker, Baclofen pump, neurostimulator, defibrillator, shunts, ECG equipment, electronic life support, high frequency operation equipment )
* Change in disease modifying treatment within the last 3 months
* Use of Botuline Toxine A within the last 3months
* Recent relapse within the last 3 months
* Acute musculoskeletal problems that hinder the test performance,
* Pregnancy
* Sizes bigger than 3XL (triple eXtra Large)
* Skin eruptions and/or skin areas in the stimulation zone that are swollen, infected or inflamed.

Where it's running

  • Nationaal MS Center Melsbroek
    Steenokkerzeel, Belgium
    Recruiting
  • The Danish MS Hospitals
    Ry, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.